ST. LOUIS, MO - In a recent transaction, Mark C. Lindgren, the Executive Vice President & Chief HR Officer of a subsidiary of Ameren Corporation (NYSE:AEE), sold 4,000 shares of the company's common stock. The sale took place on May 16, 2024, with the stock priced at $75.53 per share, amounting to a total of $302,120.
Lindgren's sale was disclosed in a Form 4 filing with the Securities and Exchange Commission. Following the transaction, Lindgren's direct holdings in Ameren Corp . decreased to 43,935 shares. The filing also noted that Lindgren holds an estimated 1,617 share equivalents in a unitized stock fund within the Ameren Corporation Savings Investment Plan, as of April 30, 2024.
The shares sold by Lindgren were part of Ameren Corp's non-derivative securities, with no derivative securities transactions reported in the filing. Additionally, the total shares owned by Lindgren following the transaction include 52 accrued dividend equivalents which were acquired during the first quarter of 2024. These were gained through a dividend reinvestment feature of restricted stock units granted under the issuer's 2022 Omnibus Incentive Compensation Plan.
Ameren Corporation, headquartered in St. Louis, Missouri, operates in the electric and other services combined industry, providing energy services to customers through its subsidiaries.
Investors and market watchers often monitor insider transactions as they can provide insights into an executive's view of the company's stock value and future performance. However, it's important to note that there can be various reasons for an insider to sell stock, and such transactions do not necessarily indicate a lack of confidence in the company.
The transaction was signed off by Jonathan T. Shade, Deputy Corporate Secretary for Ameren Corporation, acting as attorney-in-fact for Mark C. Lindgren.
InvestingPro Insights
Ameren Corporation (NYSE:AEE) has recently seen significant activity from its executives, with Mark C. Lindgren selling 4,000 shares. To provide a deeper understanding of the company's financial health and stock performance, we turn to InvestingPro for real-time data and expert analysis.
InvestingPro Data indicates that Ameren has a market capitalization of $19.83 billion and is trading at a price-to-earnings (P/E) ratio of 17.15. The company's revenue over the last twelve months as of Q1 2024 stands at $7.018 billion, reflecting a decrease of 11.21% year-over-year. Despite this revenue contraction, Ameren maintains a robust gross profit margin of 50.38%, demonstrating its ability to retain earnings relative to revenue.
Two key InvestingPro Tips highlight the company's financial strategy and market position. Ameren operates with a significant debt burden, which is an important consideration for investors assessing the company's financial leverage and risk profile. On the other hand, the company has demonstrated a commitment to returning value to shareholders by raising its dividend for 10 consecutive years, and it has maintained dividend payments for 27 consecutive years. This consistent dividend growth, most recently at 6.35%, underscores Ameren's stable cash flow and prudent capital management.
Ameren's stock generally trades with low price volatility, which may appeal to investors seeking stability in their portfolio. With analysts predicting profitability for the current year and the stock's dividend yield at 3.59%, Ameren presents a potentially attractive opportunity for income-focused investors.
To explore additional InvestingPro Tips, such as the company's PEG ratio and short-term liquidity concerns, readers can visit the dedicated InvestingPro page for Ameren at https://www.investing.com/pro/AEE. There are 5 more tips available, offering further insights into Ameren's financial performance and stock valuation. For those interested in a comprehensive analysis, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.